Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Henry

Showing results (561-570 of 573) with videos related to

Pageof 58
Sort By:
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Microvascular DysfunctionYader Sandoval, Joaquin E Cigarroa, George D Dangas, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
JACC. Cardiovascular Imaging|August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety ViewpointLeslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA|November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 24, 2019
Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think TankSrihari S Naidu, Matthew J Daniels, Sammy Elmariah, et al.
European Heart Journal|December 28, 2016
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trialJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Circulation|February 18, 2017
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells)Emerson C Perin, Michael P Murphy, Keith L March, et al.
Pageof 58

Showing results (561-570 of 573) with videos related to

Sort By:
Pageof 58
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Microvascular DysfunctionYader Sandoval, Joaquin E Cigarroa, George D Dangas, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
JACC. Cardiovascular Imaging|August 9, 2020
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety ViewpointLeslee Shaw, Raymond Y Kwong, Eike Nagel, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA|November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 24, 2019
Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think TankSrihari S Naidu, Matthew J Daniels, Sammy Elmariah, et al.
European Heart Journal|December 28, 2016
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trialJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Circulation|February 18, 2017
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells)Emerson C Perin, Michael P Murphy, Keith L March, et al.
Pageof 58